Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA)
CUSIP: G9TY5A101
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 108,236,654
- Total 13F shares
- 12,843,918
- Share change
- +12,817,676
- Total reported value
- $105,028,129
- Price per share
- $8.20
- Number of holders
- 38
- Value change
- +$104,999,517
- Number of buys
- 37
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP G9TY5A101?
CUSIP G9TY5A101 identifies ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G9TY5A101:
Top shareholders of ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BARCLAYS PLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,340,240
|
$24,349,729 | — | 09 Jan 2023 | |
| Christopher Cabell |
3/4/5
|
CMO & Head of R&D |
—
class O/S missing
|
162,060
|
$648,240 | — | 18 May 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,162
|
$17,337 | — | 31 Mar 2023 | |
| SONA ASSET MANAGEMENT (US) LLC |
13F
|
Company |
0.02%
|
24,480
|
$6,355 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Mar 2023 | |
| Hana Immunotherapeutics LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,404,274
|
— | — | 20 Mar 2023 | |
| PFIZER INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,970,022
|
— | — | 20 Mar 2023 | |
| Ewon Comfortech Co., Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,000,000
|
— | — | 20 Mar 2023 | |
| JATT Ventures, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
967,370
|
— | — | 10 Feb 2023 | |
| Josh Distler |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
— | — | 13 Jul 2021 | |
| Mir Tauhid Ali |
3/4/5
|
Chief Operating Officer, Director |
—
class O/S missing
|
30,000
|
— | — | 13 Jul 2021 | |
| Javier Cote-Sierra |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 13 Jul 2021 | |
| Garry Arthur Neil |
3/4/5
|
Director |
—
class O/S missing
|
7,652
|
— | — | 18 May 2023 |
Institutional Holders of Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) as of Q2 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.